Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,600 | 30,147 | 21,097 | 15,396 | 29,595 |
| Receivables | 7,813 | 5,397 | 7,329 | 17,371 | 5,653 |
| Inventories | 1,974 | 2,236 | 2,304 | 2,522 | 2,459 |
| Other current assets | 1,374 | 1,958 | 1,959 | 0 | 0 |
| TOTAL | $34,129 | $42,539 | $36,275 | $36,781 | $39,474 |
| Non-Current Assets | |||||
| PPE Net | 191 | 209 | 225 | 315 | 537 |
| Other Non-Current Assets | 4,466 | 4,383 | 4,396 | 2,011 | 2,167 |
| TOTAL | $4,657 | $4,592 | $4,621 | $2,326 | $2,704 |
| Total Assets | $38,786 | $47,131 | $40,896 | $39,107 | $42,178 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 12,458 | 12,673 | 12,821 |
| Accounts payable and accrued liabilities | 2,193 | 2,072 | 1,585 | 2,321 | 1,443 |
| Accrued Expenses | 12,251 | 12,837 | 12,600 | 13,101 | 14,484 |
| TOTAL | $16,219 | $16,437 | $28,908 | $29,222 | $29,396 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 21,619 | 24,578 | 27,809 |
| Deferred Revenues | 1,031 | 782 | 1,564 | 481 | N/A |
| Other Non-Current Liabilities | 5,966 | 5,308 | 6,780 | 2,212 | 2,894 |
| TOTAL | $6,512 | $5,951 | $29,028 | $27,369 | $31,358 |
| Total Liabilities | $22,731 | $22,388 | $57,936 | $56,591 | $60,754 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,179 | 17,179 | 9,490 | 9,446 | 9,249 |
| Common Shares | 2 | 2 | 1 | 1 | 9 |
| Retained earnings | -334,595 | -324,913 | -316,839 | -316,565 | -316,769 |
| TOTAL | $16,055 | $24,743 | $-17,040 | $-17,484 | $-18,576 |
| Total Liabilities And Equity | $38,786 | $47,131 | $40,896 | $39,107 | $42,178 |